Prager, G; Kisro, J; Muller-Huesmann, H; von der Heyde, E; Stubs, P; Burkle, D; Schmidt, B; Forstbauer, H; Hagemeyer, N; Reichenbach, F; Arnold, D; Fritsch, R; Gerger, A; Hegewisch-Becker, S; Vogel, A; Wagner, A; Winder, T; Koeberle, D; Stintzing, S.
Disease characteristics and real-world treatment pathways of BRAF V600E-mutant metastatic colorectal cancer patients: Analysis of 120 patients enrolled in the BERING CRC study
ANN ONCOL. 2023; 34: S11-S11.
Doi: 10.1016/j.annonc.2023.04.052
[Poster]
Web of Science
FullText
FullText_MUG